Global Narcolepsy Treatment Market, By Type (Type 1 Narcolepsy, Type 2 Narcolepsy), Drugs (Selective Histamine H3-Receptor Antagonist, Stimulants, Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Central Nervous System Depressant, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) - Industry Trends and Forecast to 2030.
Narcolepsy Treatment Market Analysis and Size
The global narcolepsy treatment market is rising steadily as a result of the rising prevalence of narcolepsy and rising healthcare expenditure. Growing R&D activities is considerably driving the global narcolepsy treatment market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings to acquire a competitive advantage.
Data Bridge Market Research analyses that the global narcolepsy treatment market which was USD 2,858.56 Million in 2022, would rocket up to USD 6,353.98 Million by 2030, and is expected to undergo a CAGR of 10.5% during the forecast period. This indicates the market value. “Handheld instruments” dominates the product segment of the global narcolepsy treatment market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Narcolepsy Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Type 1 Narcolepsy, Type 2 Narcolepsy), Drugs (Selective Histamine H3-Receptor Antagonist, Stimulants, Serotonin Reuptake Inhibitors, Tricyclic antidepressant, Central Nervous System Depressant, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Avadel (Ireland), Vallon Pharmaceuticals (U.S.), Jazz Pharmaceuticals, Inc.(Ireland), Jubilant Pharmova Limited (India), BIOPROJET (France), Hikma Pharmaceuticals PLC (UK), Amneal Pharmaceuticals LLC (U.S.), Teva Pharmaceutical Industries Ltd (Ireland), Ligand Pharmaceuticals Incorporated (U.S.), Novartis AG (Switzerland), Mylan N.V.(U.S.), Alkem Labs (India), Alembic Pharmaceuticals Limited (India), Torrent Pharmaceuticals Ltd (India), Johnson & Johnson Private Limited (U.S.), F. Hoffmann-La Roche Ltd.(Switzerland), Zydus Cadila (India)
|
|
Market Opportunities
|
|
Market Definition
The global narcolepsy treatment market refers to the pharmaceutical and therapeutic interventions, products, and services used for the management and treatment of narcolepsy, a neurological sleep disorder characterized by excessive daytime sleepiness, sudden loss of muscle tone (cataplexy), hallucinations, and disrupted night sleep patterns.
The market includes various treatment options aimed at reducing the symptoms associated with narcolepsy and improving the overall quality of life for affected individuals. These treatment modalities can include medications, such as stimulants, antidepressant, and sodium oxybate, as well as lifestyle modifications, behavioral therapies, and supportive care.
Global Narcolepsy Treatment Market Dynamics
Drivers
- Increasing Prevalence of Narcolepsy
The rising incidence and prevalence of narcolepsy globally are driving the demand for effective treatment options. The growing recognition of narcolepsy as a neurological disorder has led to increased diagnosis and treatment-seeking behaviour.
- Technological Advancements in Diagnosis
Advancements in diagnostic techniques, such as polysomnography, multiple sleep latency tests, and genetic testing, have improved the accuracy and efficiency of narcolepsy diagnosis. This has facilitated early intervention and treatment, thereby driving market growth.
Opportunities
- Technological Innovations
Advancements in drug delivery systems, digital health technologies, and telemedicine present opportunities to enhance narcolepsy treatment. Innovations such as wearable devices for symptom monitoring and telemedicine platforms for remote consultations can improve access and patient outcomes.
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising number of market players will further expand the market's growth rate in the future.
Restraint/Challenge
- High cost associated with the product manufacturing
The high cost associated with the product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.
This Global Narcolepsy Treatment Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global Narcolepsy Treatment Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- Jazz Pharmaceuticals is a leading player in the narcolepsy treatment market. They market Xyrem (sodium oxybate), an FDA-approved medication for cataplexy and excessive daytime sleepiness in narcolepsy patients
- In 2020, Jazz Pharmaceuticals acquired Cavion, Inc., a clinical-stage biotechnology company focused on developing therapies for neurological diseases, including narcolepsy. This acquisition expanded Jazz Pharmaceuticals' pipeline of potential narcolepsy treatments.
Global Narcolepsy Treatment Market Scope
The global narcolepsy treatment market is segmented on the basis of type, drugs, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Type 1 Narcolepsy
- Type 2 Narcolepsy
Drugs
- Selective Histamine H3-Receptor Antagonist
- Stimulants
- Serotonin Reuptake Inhibitors
- Tricyclic Antidepressants
- Central Nervous System Depressant
- Others
Route of Administration
- Oral
- Injectable
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Narcolepsy Treatment Market Regional Analysis/Insights
Global narcolepsy treatment market is analyzed, and market size insights and trends are provided by type, drugs, route of administration, end-users, and distribution channel as referenced above.
The countries covered in the global narcolepsy treatment market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa.
North America dominates the market due to factors including rising healthcare costs, increased R & D and trending technological advancements.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favourable government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Narcolepsy Treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Narcolepsy Treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Narcolepsy Treatment market. The data is available for historic period 2015-2021
Competitive Landscape and Narcolepsy Treatment Market Share Analysis
The Narcolepsy Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Narcolepsy Treatment market.
Some of the major players operating in the Narcolepsy Treatment market are:
- Avadel (Ireland)
- Vallon Pharmaceuticals (U.S.)
- Jazz Pharmaceuticals, Inc.(Ireland)
- Jubilant Pharmova Limited (India)
- BIOPROJET (France)
- Hikma Pharmaceuticals PLC (UK)
- Amneal Pharmaceuticals LLC (U.S.)
- Teva Pharmaceutical Industries Ltd (Ireland)
- Ligand Pharmaceuticals Incorporated (U.S.)
- Novartis AG (Switzerland)
- Mylan N.V.(U.S.)
- Alkem Labs (India)
- Alembic Pharmaceuticals Limited (India)
- Torrent Pharmaceuticals Ltd (India)
- Johnson & Johnson Private Limited (U.S.)
- F. Hoffmann-La Roche Ltd.(Switzerland)
- Zydus Cadila (India)
SKU-